ZENTEK LTD. Total Liabilities
ZENTEK LTD. total liabilities. Based on the latest financial reports, ZENTEK LTD. (ZAY0) has total liabilities worth €5.04 Million EUR (≈ $5.90 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ZAY0 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of ZENTEK LTD. (2022–2025)
Total liabilities of ZENTEK LTD. from 2022 to 2025. This chart illustrates how ZENTEK LTD.'s total liabilities have evolved over time, based on quarterly financial data.
ZENTEK LTD. Competitors by Total Liabilities
The table below lists competitors of ZENTEK LTD. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Turism Hotelur
RO:EFO
|
Romania | RON36.76 Million |
|
Elicio Therapeutics Inc.
NASDAQ:ELTX
|
USA | $23.39 Million |
|
TWL Holdings Bhd
KLSE:7079
|
Malaysia | RM148.38 Million |
|
Routon Electronic Co Ltd
SHG:600355
|
China | CN¥147.15 Million |
|
ENERGY&MACHINERY KOREA Co.Ltd
KQ:095190
|
Korea | ₩125.37 Billion |
|
Aarti Surfactants Limited
NSE:AARTISURF
|
India | Rs2.53 Billion |
|
Selangor Dredging Bhd
KLSE:2224
|
Malaysia | RM616.84 Million |
|
Stalprofil S.A.
WAR:STF
|
Poland | zł613.12 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down ZENTEK LTD.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ZAY0 total asset value.
Liquidity & Leverage Metrics
ZENTEK LTD. Total Liabilities Ratios Explained
ZENTEK LTD. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ZENTEK LTD.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ZENTEK LTD. (2022–2025)
The table below shows the annual total liabilities of ZENTEK LTD. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €3.65 Million ≈ $4.26 Million |
+51.20% |
| 2024-03-31 | €2.41 Million ≈ $2.82 Million |
-16.97% |
| 2023-03-31 | €2.90 Million ≈ $3.40 Million |
-15.45% |
| 2022-03-31 | €3.44 Million ≈ $4.02 Million |
-- |
About ZENTEK LTD.
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more